UK urges adults 65+ and 70–80 to get Shingrix vaccine, with low uptake reported.

Health officials in the UK are urging adults over 65 and those aged 70 to 80 to get the Shingrix shingles vaccine, as fewer than half of eligible individuals have received their first dose, with uptake at 42.1% for those turning 66. The two-dose vaccine, offered free by the NHS, is highly effective in preventing shingles, a painful condition caused by reactivated chickenpox virus, which can lead to long-term nerve pain and complications. In India, shingles remains underrecognized, with limited awareness and low discussion with doctors, despite high rates of chronic disease and severe pain among patients. GSK is promoting vaccination in India and advocating for routine adult immunization, while in South Africa, Shingrix is expected to become available later in 2026, though cost remains a barrier.